Skye Bioscience Inc (SKYE)
5.51
+0.20
(+3.77%)
USD |
NASDAQ |
Nov 14, 16:00
5.53
+0.02
(+0.36%)
After-Hours: 20:00
Skye Bioscience Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2014 | 10.91% |
| April 30, 2014 | -18.55% |
| January 31, 2014 | 5.71% |
| October 31, 2013 | -6.24% |
| Date | Value |
|---|---|
| July 31, 2013 | -0.78% |
| April 30, 2013 | 1.90% |
| January 31, 2013 | 0.28% |
| October 31, 2012 | 28.66% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Oramed Pharmaceuticals Inc | -- |
| Viking Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |